Literature DB >> 9224711

Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain.

L Duprez1, J Parma, S Costagliola, J Hermans, J Van Sande, J E Dumont, G Vassart.   

Abstract

Activating mutations of the TSH receptor gene have been found in toxic adenomas and hereditary toxic thyroid hyperplasia. Up to now, all mutations have been located in the serpentine portion of the receptor. We now describe two additional mutations affecting Ser-281 (Ser-281-Thr and Ser-281-Asn) in the ectodomain of the receptor. After transfection in COS cells, both mutants displayed increased constitutive activity for cAMP generation despite expression at a lower level than the wild type. The mutants were responsive to TSH. The present results are compatible with a model in which the activity of the unliganded receptor is kept at a low level by an inhibitory interaction between the N-terminal domain and the serpentine portion of the receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224711     DOI: 10.1016/s0014-5793(97)00532-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  Constitutive activation of tethered-peptide/corticotropin-releasing factor receptor chimeras.

Authors:  S M Nielsen; L Z Nielsen; S A Hjorth; M H Perrin; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

2.  The Activation Mechanism of Glycoprotein Hormone Receptors with Implications in the Cause and Therapy of Endocrine Diseases.

Authors:  Antje Brüser; Angela Schulz; Sven Rothemund; Albert Ricken; Davide Calebiro; Gunnar Kleinau; Torsten Schöneberg
Journal:  J Biol Chem       Date:  2015-11-18       Impact factor: 5.157

3.  Evidence for activity-regulated hormone-binding cooperativity across glycoprotein hormone receptor homomers.

Authors:  Maxime Zoenen; Eneko Urizar; Stéphane Swillens; Gilbert Vassart; Sabine Costagliola
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 4.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

5.  Ligand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor.

Authors:  Hamiyet Unal; Rajaganapathi Jagannathan; Manjunatha B Bhat; Sadashiva S Karnik
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

6.  Structure of a Thyrotropin Receptor Monoclonal Antibody Variable Region Provides Insight into Potential Mechanisms for its Inverse Agonist Activity.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Paul A Hubbard; Randall McNally; Ramachandran Murali; Basil Rapoport
Journal:  Thyroid       Date:  2018-06-29       Impact factor: 6.568

7.  The superagonistic activity of bovine thyroid-stimulating hormone (TSH) and the human TR1401 TSH analog is determined by specific amino acids in the hinge region of the human TSH receptor.

Authors:  Sandra Mueller; Gunnar Kleinau; Mariusz W Szkudlinski; Holger Jaeschke; Gerd Krause; Ralf Paschke
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

8.  The thyrotropin receptor hinge region as a surrogate ligand: identification of loci contributing to the coupling of thyrotropin binding and receptor activation.

Authors:  Chun-Rong Chen; Larry M Salazar; Sandra M McLachlan; Basil Rapoport
Journal:  Endocrinology       Date:  2012-10       Impact factor: 4.736

9.  The thyrotropin receptor hinge region is not simply a scaffold for the leucine-rich domain but contributes to ligand binding and signal transduction.

Authors:  Yumiko Mizutori; Chun-Rong Chen; Sandra M McLachlan; Basil Rapoport
Journal:  Mol Endocrinol       Date:  2008-01-24

10.  Lack of consistent association of thyrotropin receptor mutations in vitro activity with the clinical course of patients with sporadic non-autoimmune hyperthyroidism.

Authors:  J Lueblinghoff; S Mueller; J Sontheimer; R Paschke
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.